Literature DB >> 21252666

Central compartment dissection for well differentiated thyroid cancer … and the band plays on.

N Gopalakrishna Iyer1, Ashok R Shaha.   

Abstract

PURPOSE OF REVIEW: The role of central compartment dissection in the surgical management of well differentiated thyroid cancer is controversial. Lack of high-quality prospective studies results in management decisions being based on expert opinions and weaker levels of evidence. The American Thyroid Association has recently revised its management guidelines with particular emphasis on this topic, and a separate working group has set out to define the surgical anatomy that encompasses this procedure. RECENT
FINDINGS: Central compartment dissection comprises the removal of nodal tissue from the prelaryngeal, pretracheal and paratracheal compartments, with no role for berry-picking procedures. There is universal agreement that therapeutic nodal dissection should be performed in patients with metastatic disease detected either through preoperative imaging or during intraoperative evaluation of the central compartment, with either visual inspection or frozen-section pathology. In contrast, there may be limited benefit from routine prophylactic central compartment dissection, for either disease recurrence or survival outcomes. As such, it should be performed only in patients deemed high risk: larger tumors, extra-thyroidal extension or aggressive histologic subtypes.
SUMMARY: Future studies should focus on identifying the subpopulation of patients who would most benefit from these procedures and spare low-risk patients from the unwanted complications.

Entities:  

Mesh:

Year:  2011        PMID: 21252666     DOI: 10.1097/MOO.0b013e328343af58

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  7 in total

1.  In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.

Authors:  Mauricio A Moreno; Beth S Edeiken-Monroe; Eric R Siegel; Steven I Sherman; Gary L Clayman
Journal:  Thyroid       Date:  2012-01-26       Impact factor: 6.568

Review 2.  The prognostic implication and potential role of BRAF mutation in the decision to perform elective neck dissection for thyroid cancer.

Authors:  Jin Woo Lee; Bon Seok Koo
Journal:  Gland Surg       Date:  2013-11

3.  Pattern of nodal involvement in papillary thyroid cancer: a challenge of quantitative analysis.

Authors:  Fausto Fama; Marco Cicciù; Giuseppe Lo Giudice; Alessandro Sindoni; Jessica Palella; Arnaud Piquard; Olivier Saint-Marc; Salvatore Benvenga; Ennio Bramanti; Gabriele Cervino; Maria Gioffre Florio
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 4.  Occult thyroid carcinoma: a rare case report and review of literature.

Authors:  Haiguang Liu; Lin Lv; Kai Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

5.  BRAF V600E mutation correlates with aggressive clinico-pathological features but does not influence tumor recurrence in papillary thyroid carcinoma-10-year single-center results.

Authors:  Navid Tabriz; Johannes Grone; Verena Uslar; Andrea Tannapfel; Dirk Weyhe
Journal:  Gland Surg       Date:  2020-12

6.  Predictive factors of right paraesophageal lymph node metastasis in papillary thyroid carcinoma: Single center experience and meta-analysis.

Authors:  Young Min Park; Sang Min Lee; Dong Won Kim; Sung-Chan Shin; Byung-Joo Lee
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

7.  Lymph Node Dissection for Differentiated Thyroid Cancer.

Authors:  Aviram Mizrachi; Ashok R Shaha
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.